Trial · NCT03772925
Results by group72
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 72
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Recommended Phase 2 Dose (RP2D) for the Combination of MLN4924 (Pevonedistat) and Belinostat | Treatment (Belinostat, Pevonedistat) Dose Level 1 | 0 | Participants | ||
| Recommended Phase 2 Dose (RP2D) for the Combination of MLN4924 (Pevonedistat) and Belinostat | Treatment (Belinostat, Pevonedistat) Dose Level 2 | 0 | Participants | ||
| Recommended Phase 2 Dose (RP2D) for the Combination of MLN4924 (Pevonedistat) and Belinostat | Treatment (Belinostat, Pevonedistat) Dose Level 3 | 0 | Participants | ||
| Recommended Phase 2 Dose (RP2D) for the Combination of MLN4924 (Pevonedistat) and Belinostat | Treatment (Belinostat, Pevonedistat) Dose Level 4 | 0 | Participants | ||
| Recommended Phase 2 Dose (RP2D) for the Combination of MLN4924 (Pevonedistat) and Belinostat | Treatment (Belinostat, Pevonedistat) Dose Level 5 | 0 | Participants | ||
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 1 | Number of Grade 1 AE's | 57 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 2 | Number of Grade 1 AE's | 34 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 3 | Number of Grade 1 AE's | 75 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 4 | Number of Grade 1 AE's | 49 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 5 | Number of Grade 1 AE's | 127 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 1 | Number of Grade 2 AE's | 19 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 2 | Number of Grade 2 AE's | 11 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 3 | Number of Grade 2 AE's | 69 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 4 | Number of Grade 2 AE's | 42 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 5 | Number of Grade 2 AE's | 17 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 1 | Number of Grade 3 AE's | 13 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 2 | Number of Grade 3 AE's | 6 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 3 | Number of Grade 3 AE's | 33 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 4 | Number of Grade 3 AE's | 19 | Adverse Events Reported | |
| Incidence of Adverse Events (AEs) | Treatment (Belinostat, Pevonedistat) Dose Level 5 | Number of Grade 3 AE's | 7 | Adverse Events Reported |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03772925/results